366 related articles for article (PubMed ID: 17931755)
1. Failure of a Mycobacterium tuberculosis DeltaRD1 DeltapanCD double deletion mutant in a neonatal calf aerosol M. bovis challenge model: comparisons to responses elicited by M. bovis bacille Calmette Guerin.
Waters WR; Palmer MV; Nonnecke BJ; Thacker TC; Scherer CF; Estes DM; Jacobs WR; Glatman-Freedman A; Larsen MH
Vaccine; 2007 Nov; 25(45):7832-40. PubMed ID: 17931755
[TBL] [Abstract][Full Text] [Related]
2. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.
Hope JC; Thom ML; Villarreal-Ramos B; Vordermeier HM; Hewinson RG; Howard CJ
Clin Exp Immunol; 2005 Jan; 139(1):48-56. PubMed ID: 15606613
[TBL] [Abstract][Full Text] [Related]
3. Adaptive immunity in the colostrum-deprived calf: response to early vaccination with Mycobacterium bovis strain bacille Calmette Guerin and ovalbumin.
Nonnecke BJ; Waters WR; Goff JP; Foote MR
J Dairy Sci; 2012 Jan; 95(1):221-39. PubMed ID: 22192201
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium bovis Δmce2 double deletion mutant protects cattle against challenge with virulent M. bovis.
Blanco FC; Bianco MV; Garbaccio S; Meikle V; Gravisaco MJ; Montenegro V; Alfonseca E; Singh M; Barandiaran S; Canal A; Vagnoni L; Buddle BM; Bigi F; Cataldi A
Tuberculosis (Edinb); 2013 May; 93(3):363-72. PubMed ID: 23518075
[TBL] [Abstract][Full Text] [Related]
5. Immune response to postprimary tuberculosis in mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin induce equal protection.
Mollenkopf HJ; Kursar M; Kaufmann SH
J Infect Dis; 2004 Aug; 190(3):588-97. PubMed ID: 15243936
[TBL] [Abstract][Full Text] [Related]
6. Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines.
Wedlock DN; Aldwell FE; Vordermeier HM; Hewinson RG; Buddle BM
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):220-7. PubMed ID: 22005585
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis.
Williams A; Davies A; Marsh PD; Chambers MA; Hewinson RG
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S299-301. PubMed ID: 10875804
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle.
Mustafa AS; Skeiky YA; Al-Attiyah R; Alderson MR; Hewinson RG; Vordermeier HM
Infect Immun; 2006 Aug; 74(8):4566-72. PubMed ID: 16861643
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium bovis DeltaleuD auxotroph-induced protective immunity against tissue colonization, burden and distribution in cattle intranasally challenged with Mycobacterium bovis Ravenel S.
Khare S; Hondalus MK; Nunes J; Bloom BR; Garry Adams L
Vaccine; 2007 Feb; 25(10):1743-55. PubMed ID: 17240005
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium tuberculosis DeltaRD1 DeltapanCD: a safe and limited replicating mutant strain that protects immunocompetent and immunocompromised mice against experimental tuberculosis.
Sambandamurthy VK; Derrick SC; Hsu T; Chen B; Larsen MH; Jalapathy KV; Chen M; Kim J; Porcelli SA; Chan J; Morris SL; Jacobs WR
Vaccine; 2006 Sep; 24(37-39):6309-20. PubMed ID: 16860907
[TBL] [Abstract][Full Text] [Related]
12. Development of a Mycobacterium bovis intranasal challenge model in mice.
Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
[TBL] [Abstract][Full Text] [Related]
13. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J
Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343
[TBL] [Abstract][Full Text] [Related]
14. Antigen load governs the differential priming of CD8 T cells in response to the bacille Calmette Guerin vaccine or Mycobacterium tuberculosis infection.
Ryan AA; Nambiar JK; Wozniak TM; Roediger B; Shklovskaya E; Britton WJ; Fazekas de St Groth B; Triccas JA
J Immunol; 2009 Jun; 182(11):7172-7. PubMed ID: 19454714
[TBL] [Abstract][Full Text] [Related]
15. An ESAT-6:CFP10 DNA vaccine administered in conjunction with Mycobacterium bovis BCG confers protection to cattle challenged with virulent M. bovis.
Maue AC; Waters WR; Palmer MV; Nonnecke BJ; Minion FC; Brown WC; Norimine J; Foote MR; Scherer CF; Estes DM
Vaccine; 2007 Jun; 25(24):4735-46. PubMed ID: 17499400
[TBL] [Abstract][Full Text] [Related]
16. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
[TBL] [Abstract][Full Text] [Related]
17. Toward the development of diagnostic assays to discriminate between Mycobacterium bovis infection and bacille Calmette-Guérin vaccination in cattle.
Vordermeier HM; Cockle PJ; Whelan AO; Rhodes S; Hewinson RG
Clin Infect Dis; 2000 Jun; 30 Suppl 3():S291-8. PubMed ID: 10875803
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical markers augment evaluation of vaccine efficacy and disease severity in bacillus Calmette-Guerin (BCG) vaccinated cattle challenged with Mycobacterium bovis.
Johnson L; Gough J; Spencer Y; Hewinson G; Vordermeier M; Wangoo A
Vet Immunol Immunopathol; 2006 Jun; 111(3-4):219-29. PubMed ID: 16540176
[TBL] [Abstract][Full Text] [Related]
19. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine.
Pinto R; Saunders BM; Camacho LR; Britton WJ; Gicquel B; Triccas JA
J Infect Dis; 2004 Jan; 189(1):105-12. PubMed ID: 14702160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
